A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial

• Emmanuel Maheu ,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: emaheu@wanadoo.fr

  Affiliation Department of Rheumatology, AP-HP, Hôpital Saint-Antoine, Paris, France, Private office, Paris, France

  http://orcid.org/0000-0001-6615-3630

  ⨯
• Bernard Avouac,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Department of Rheumatology, CHU Henri Mondor, Créteil, France (currently: rheumatologist, consultant, Paris, France)

  ⨯
• Renée Liliane Dreiser,

  Roles Methodology, Writing – review & editing

  Affiliation Department of Rheumatology, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France

  ⨯
• Thomas Bardin

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Department of Rheumatology, AP-HP, Hôpital Lariboisière, Université Paris Diderot, Paris, France

  ⨯